Chittorgarh.com Logo
Loading...

Laurus Labs Ltd IPO (Laurus Labs IPO) Detail

Dec 6, 2016 - Dec 8, 2016

Incorporated in 2005, Laurus Labs Ltd is Hyderabad based pharmaceutical company. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.

Laurus Labs operates in four business lines:
1. Generics active pharmaceutical ingredients (APIs) - The development, manufacture and sale of APIs and advanced intermediates.
2. Generics finished dosage forms (FDFs) - The development and manufacture of oral solid formulations.
3. Synthesis - Contract development and manufacturing services for global pharmaceutical companies.
4. Ingredients - The manufacture and sale of specialty ingredients for use in the nutraceutical and cosmeceutical sectors.

Key Highlights:
1. Laurus Labs launched 59 products since our inception in 2005.
2. Nine out of the 10 largest generic pharmaceutical companies in the world are its customers.
3. Laurus Labs employed 587 scientists at our R&D center in Hyderabad and 12 scientists at R&D centre in Greater Boston USA.
4. The Company owned 32 patents and had 150 pending patent applications, in several countries.
5. Company has three manufacturing facilities in Visakhapatnam, Andhra Pradesh.
6. Company sells its products in 32 countries in Sub-Saharan Africa, South-East Asia and Latin America.

Key Strengths:
1. Leadership in APIs in Select, High Growth Therapeutic Areas
2. Strong R&D Capabilities and Process Chemistry Skills
3. Industry Leading, Modern and Regulatory Compliant Manufacturing Capacities
4. Long-standing Relationships with Multi-National Pharmaceutical Companies
5. Experienced Promoters and Qualified Operational Personnel
6. Established Track Record of Delivering Growth

Company Promoters:

The Promoters of the company are:

1. Dr Satyanarayana Chava
2. Naga Rani Chava
3. Dr Raju Srihari Kalidindi
4. Ravi Kumar V V and
5. Dr Lakshmana Rao C V

Company Financials:

Summary of financial Information
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 23,083.48 18,925.49 12,730.58 7,009.89 5,128.78
Total Revenue 17,884.15 13,603.80 11,685.34 7,235.67 4,523.07
Profit After Tax (PAT) 1,435.68 735.17 972.17 882.19 215.77

Objects of the Issue:

The object of the issue are to:
1. Pre-payment of term loans; and
2. General corporate purposes.

Laurus Labs IPO Details

IPO Opening Date Dec 6, 2016
IPO Closing Date Dec 8, 2016
Issue Type Book Built Issue IPO
Face Value ₹10 per equity share
IPO Price ₹426 to ₹428 per equity share
Market Lot 35 Shares
Min Order Quantity 35 Shares
Listing At BSE, NSE
Issue Size31,116,785 Eq Shares of ₹10
(aggregating up to ₹1,331.80 Cr)
Fresh Issue7,009,345 Eq Shares of ₹10
(aggregating up to ₹300.00 Cr)
Offer for Sale24,107,440 Eq Shares of ₹10
(aggregating up to ₹1,031.80 Cr)

Laurus Labs IPO Tentative Timetable

The Laurus Labs IPO open date is Dec 6, 2016, and the close date is Dec 8, 2016. The issue may list on Dec 19, 2016.

IPO Open Date Dec 6, 2016
IPO Close Date Dec 8, 2016
Basis of Allotment Date Dec 14, 2016
Initiation of Refunds Dec 15, 2016
Credit of Shares to Demat Account Dec 16, 2016
IPO Listing Date Dec 19, 2016

Laurus Labs IPO Lot Size

The Laurus Labs IPO market lot size is 35 shares. A retail-individual investor can apply for up to 13 lots (455 shares or ₹194,740).

Application Lots Shares Amount (Cut-off)
Minimum 1 35 ₹14,980
Maximum 13 455 ₹194,740

Laurus Labs IPO Review

Company is having good contracts from world leaders and enjoys leadership position in APIs and generics. Investments made by the company will start adding to revenues and profits from FY 18 onwards and thus poised for bright prospects. Although issue appears to have been priced in line with peer’s trending, it may be considered for medium to long term investment. Read detail review...

Laurus Labs IPO Subscription Status (Bidding Detail)

The Laurus Labs IPO is subscribed 4.53 times on 12/8/2016 6:18:00 PM. The public issue subscribed 1.58 times in the retail category, 10.54 times in the QIB category, and 3.57 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)
QIB10.54
NII3.57
Retail1.58
Employee1.71
Total4.53

Laurus Labs IPO Prospectus

Laurus Labs IPO Rating

774
4.2
Rating:Rated 4.2 stars
Vote Here ...

Laurus Labs IPO Listing Date

Listing Date Monday, December 19, 2016
BSE Script Code 540222
NSE Symbol LAURUSLABS
Listing In B Group of Securities
ISIN INE947Q01010
IPO Price ₹428 per equity share
Face Value ₹10 per equity share

Listing Day Trading Information

.
IPO Price
Open
Low
High
Last Trade
BSE
₹428.00
₹490.00
₹475.00
₹498.00
₹480.50
NSE
₹428.00
₹489.90
₹475.00
₹498.00
₹480.40

Company Contact Information

Laurus Labs Ltd
Plot No.21,
Jawaharlal Nehru Pharma City,
Parawada, Visakhapatnam 531 021
Phone: + 91 40 3980 4333
Email: secretarial@lauruslabs.com
Website: http://www.lauruslabs.com

Laurus Labs IPO Registrar

KFintech Private Limited

Phone: 04067162222, 04079611000
Email: einward.ris@karvy.com
Website: https://karisma.kfintech.com/

Laurus Labs IPO Reviews / Ratings

  • Ajcon Global Services Ltd - Apply
  • Dilip Davda - Apply
  • Hem Securities - Avoid
  • KR Choksey Securities Ltd - Apply

Laurus Labs IPO FAQs

Laurus Labs IPO is a main-board IPO of 31,116,785 equity shares of the face value of ₹10 aggregating up to ₹1,331.80 Crores. The issue is priced at ₹426 to ₹428 per equity share. The minimum order quantity is 35 Shares.

The IPO opens on Dec 6, 2016, and closes on Dec 8, 2016.

KFintech Private Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

The Laurus Labs IPO opens on Dec 6, 2016 and closes on Dec 8, 2016.

Laurus Labs IPO lot size is 35 Shares and the minimum order quantity is 35 Shares.

You can apply in Laurus Labs IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Laurus Labs IPO will be done on Dec 14, 2016, and the allotted shares will be credited to your demat account by Dec 16, 2016. Check the Laurus Labs IPO allotment status.

The Laurus Labs IPO listing date is on Monday, December 19, 2016.

Laurus Labs IPO Message Board

Ranked Members  Ranked Members

Loading...

2548 Comments

1304. Hardik Chudgar |Feb 21, 2017 3:10:10 PM
Laurus jumps around 518. Should wait or exit??
1303. nona |Feb 21, 2017 12:52:11 PM
gamble ji

lauras lab kab jagega

thank u
1302. A patel..Gujarat.. |Feb 16, 2017 1:24:59 PM
Laurus exit tatget 428..few days..exit.. issue prise coming up..
1301. rvr |Feb 16, 2017 9:14:37 AM
laurus will sail to 580 shortly
1300. rvr |Feb 16, 2017 9:14:05 AM
LAURUS will reach 580 in 2 days...
1299. A patel..Gujarat.. |Feb 15, 2017 2:58:04 PM
Exit laurus lab. And Buy Sun farma...Best Retun in Short time..
1298. NPT |Feb 10, 2017 8:01:26 PM
Top Contributor Top Contributor (200+ Posts, 300+ Likes)
I have positive outlook on Laurus Labs for the 4th quarter result because company will be benefitted from operation of its new unit which started production in Nov 2016. The company is expected to get some parents during the quarter. Company bottom line will improve because of payment of debts to the tune of R''s.226 crores from the ipo proceeds. There is a chance that in the short run it may test R''s.480 level again.
1298.1. AKH |Feb 11, 2017 1:35:15 PM
IPO Mentor IPO Mentor (900+ Posts, 700+ Likes)
The company is expected to get "Some Parents" what is this ?
1298.2. NPT |Feb 11, 2017 4:24:55 PM
Top Contributor Top Contributor (200+ Posts, 300+ Likes)
It is a typing mistake. It is patent, not parents.
1297. CLD |Feb 10, 2017 12:12:27 PM
IPO Mentor IPO Mentor (500+ Posts, 100+ Likes)
No body is answering the question of people about selling or holding of the shares they are holding. I have already got my whats up group members to book part profits yesterday at 560. I don''t know why people are not helping others. No body is expert in market still experienced people can give suggestions. My previous posts can be seen by clicking on my name.
1297.3. Shivajee |Feb 16, 2017 7:47:26 AM
IPO Mentor IPO Mentor (700+ Posts, 100+ Likes)
I like this post by CLD. True. But gamble is very helpful, he responds to questions by the inexperienced.

Nobody says how they became experts also. It is better to teach people how to catch fish rather than catching them, cooking and then feeding to people.

1297.4. nona |Feb 16, 2017 12:00:42 PM
shivajee sir

I do agree with YOU
1296. gamble |Feb 10, 2017 9:20:26 AM
IPO Guru IPO Guru (1600+ Posts, 3900+ Likes)
Avg. set of numbers.
...stock already priced in this type of no.s
1295. VALUE INVESTOR |Feb 10, 2017 4:48:38 AM
IPO Mentor IPO Mentor (900+ Posts, 600+ Likes)
http://www.moneycontrol.com/news/results/laurus-labs-net-profit175-to-rs472-croreq3_8465141.html

Laurus Laboratories posted a 17.5 percent increase in net profit to Rs 47.2 crore in the third quarter ended December on account of larger uptake of its API business.
1295.1. Cbm |Feb 10, 2017 11:10:43 AM
Experts,
kindly let me you views about Laurus Lab
whether it sell or hold
1295.2. AKH |Feb 10, 2017 4:51:09 PM
IPO Mentor IPO Mentor (900+ Posts, 700+ Likes)
@CBM
Actually experts dont reply. My opinion is to hold till results of next quarter, if you can
1294. Umang & his ultrasonic uproar |Feb 9, 2017 7:58:21 PM
Laurus labs result is out... Pls see on bse site(corporate announcements). Pls analyze Mr Septa, Mr gamble and help us understand weather it is good or not
1294.1. NPT |Feb 9, 2017 9:13:55 PM
Top Contributor Top Contributor (200+ Posts, 300+ Likes)
One more positive note in the result is that its total revenue and pat for December 16 quarter has increased in comparison to the December 2015 quarter''s results.
1294.2. VALUE INVESTOR |Feb 9, 2017 9:30:36 PM
IPO Mentor IPO Mentor (900+ Posts, 600+ Likes)
Let''s see how market react tomorrow.
1293. Chem cho |Feb 8, 2017 5:57:48 PM
IPO Guru IPO Guru (2200+ Posts, 2300+ Likes)
Laurus was trading between 475 to 480 from jan 17 from 3 feb movement was seen in this script now it has risen to high of RS 585 and todays low of Rs 546

script is worth holding at ipo price those who got allotment for better target than Rs 600



1292. deepika |Feb 7, 2017 3:52:25 PM
LAURUS LAB

TARGET 600-650 FEB MONTH 100%
1292.1. AJ''s Actions |Feb 7, 2017 6:29:04 PM
Is this true news?
1292.2. rvr |Feb 8, 2017 9:01:06 PM
in market nothing is true....only predictions..
1291. deepika |Feb 7, 2017 3:52:23 PM
LAURUS LAB

TARGET 600-650 FEB MONTH 100%
1290. deepika |Feb 7, 2017 3:18:58 PM
KINDLY BUY LAURUS

TARGET 590 ONLY 2 DAYS
1289. A patel..Gujarat.. |Feb 7, 2017 1:51:02 PM
2 lot sold. 583.70...
1288. CA M&co.Jodhpur |Feb 7, 2017 11:30:55 AM
Sell Laurus lab and buy Alkem Lab for best return in this year.
Alkem lab near 52week high very strong fundamental strong pharmaceutical company.
1288.1. CA M&co.Jodhpur |Feb 13, 2017 12:54:19 PM
My expectations is correct.see Alkem Lab at new 52 week high.and laurus down.
Buy Alkem Lab instead of Lauruse lab.
1287. s.selvam |Feb 6, 2017 9:23:51 PM
Though I have not been allotted in BSE IPO I have been allotted LAURUS LAB AND IT TESTED MY PATIENCE FOR QUITE A LONG TIME.IT OSCILATES AROUND RS.472/- TO RS.480/- FOR QUITE A LONG TIME.EAGLE EYE MADAM I THANK U AFTER SEEING YOUR MESSAGE TO HOLD. I HAVE NOT SOLD THOSE SHARES.NOW I AM REACHING THE BENEFITS.LATER ONLY I KNOW THAT THEY ARE ONE OF API OF MEDICINES FOR ONCOLOGY AND HEPATITIS.I THANK ONCE AGAIN EAGLE EYE MADAM I AM HOLDING 70 SHARES OF LL WHICH I WILL GIFT IT TO MY GRAND DAUGHTER AND GRAND SON..
1286. CA Bhaumik Shah |Feb 6, 2017 6:39:43 PM
Dear Eagleye

What will be the next target ?
Whether it may go to 650 to 700 ?
1285. Eagleye |Feb 6, 2017 1:54:10 PM
IPO Guru IPO Guru (6100+ Posts, 20200+ Likes)
Laurus 🚀🚀🚀
1285.4. NPT |Feb 6, 2017 10:15:09 PM
Top Contributor Top Contributor (200+ Posts, 300+ Likes)
Laurus will fire like Agni5000. For this reason we have to wait and watch its next two Quarters'' result. If during this period its result continues to show the recent past growth rate and if it receives a couple of patent in the meantime, it will be another Glenmark.
1285.5. Shivajee |Feb 7, 2017 8:48:19 AM
IPO Mentor IPO Mentor (700+ Posts, 100+ Likes)
People were so praising of Adv Enzymes like Laurus labs. But it came down to 1800 levels.

We should look at "on what basis it will shoot like agni or rocket" really.